An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue SUPPL. C, 1996, Pages 71-81

  O'Doherty, B ^a  

^a Merrion Lodge   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; EAR NOSE THROAT DISEASE; FEMALE; FLATULENCE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; REINFECTION; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SINUSITIS; SKIN DISEASE; STREPTOCOCCUS PYOGENES; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION; UROGENITAL TRACT DISEASE; VOMITING;

EID: 0029841845     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.suppl_c.71     Document Type: Article

References (34)

1. Andersen, G., Esmonde, T. S., Coles, S., Macklin, J. & Carnegie, C. (1991). A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia. Journal of Antimicrobial Chemotherapy 27, Suppl. A, 117-24.
2. Aronoff, S. C., Laurent, C. & Jacobs, M. R. (1987). In-vitro activity of erythromycin, eroxithromycin and CP-62993 against common paediatric pathogens. Journal of Antimicrobial Chemotherapy 19, 275-6.
3. Bauer, A. W., Kirby W. M. M., Sherds, J. C. & Turck, M. (1966). Antibiotic susceptibility testing by a standardized single disk method. American Journal of Clinical Pathology 45, 493-6.
4. Bergman, A. B. & Werner, R. J. (1963). Failure of children to receive penicillin by mouth. New England Journal of Medicine 268, 1334-8.
5. Bright, G. M., Nagel, A. A., Bordner, J., Desai, K. A., Dibrino, J. N., Nowakowska, J. et al. (1988). Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoery-thromycin A derivatives: a new class of macrolide antibiotics, the azalides. Journal of Antibiotics 41, 1029-47.
6. Carbon, C. (1988). Cefaclor therapy for specific upper respiratory tract infections: pharyngitis, purulent rhinitis, laryngotracheitis. Clinical Therapeutics 11, Suppl. A, 48-53.
7. Cockburn, J., Gibberd, R. W., Reid, A. L. & Sanson-Fisher, R. W. (1987). Determinants of non-compliance with short-term antibiotic regimens. British Medical Journal 295, 814-8.
8. Cohen, R., de La Rocque, F., Boucherat, M., Lecompte, M. D., Bouhanna, A., Wollner, A. et al. (1991). Etude cefaclor versus pénicilline V dans le angines streptococciques de l'enfant. Annales de Pediatrie 38, 289-95.
9. Colcher, I. S. & Bass, J. W. (1972). Penicillin treatment of streptococcal pharyngitis. A comparison of schedules and the role of specific counselling. Journal of the American Medical Association 222, 657-9.
10. Daniel, R. R. (1993). Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children. Journal of Antimicrobial Chemotherapy 31, Suppl. E, 65-71.
11. Dunkin, K. T., Jones, S. & Howard, A. J. (1988). The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella cattarhalis, staphylococci and streptococci. Journal of Antimicrobial Chemotherapy 21, 405-11.
12. Foulds, G., Chan, K. H., Johnson, J. T., Shepard, R. M. & Johnson, R. B. (1991). Concentrations of azithromycin in human tonsillar tissue. European Journal of Clinical Microbiology and Infectious Diseases 10, 853-6.
13. Foulds, G. & Johnson, R. B. (1993). Selection of dose regimens of azithromycin. Journal of Antimicrobial Chemotherapy 31, Suppl. E, 39-50.
14. Gatley, M. S. (1968). To be taken as directed. Journal of the Royal College of General Practitioners 16, 39-44.
15. Girard, A. E., Girard, D., English, A. R., Gootz, T. D., Cimochowski, C. R., Faiella, J. A. et al. (1987). Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrobial Agents and Chemotherapy 31, 1948-54.
16. Greenberg, R. N. (1984). Overview of palient compliance with medication dosing: a literature review. Clinical Therapeutics 6, 592-9.
17. Hamill, J. (1993). Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children. Journal of Antimicrobial Chemotherapy 31, Suppl. E, 89-94.
18. Hardy, D. J., Hensey, D. M., Beyer, J. M., Vojtko, C., McDonald, E. J. & Fernandes, P. B. (1988). Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrobial Agents and Chemotherapy 32, 1710-9.
19. Iliopoulou, A., Aldhous, M. E., Johnston, A. & Turner, P. (1982). Pharmacokinetic interaction between theophylline and erythromycin. British Journal of Clinical Pharmacology 14, 495-9.
20. Mathews, D. R., McNutt, B., Oberholm, R., Flicker, M. & McBride, G. (1991). Torsades de pointes occurring in association with terfenadine use. Journal of the American Medical Association 266, 2375-6.
21. McLinn, S. E. (1988). Cefaclor: a decade of experience in acute otitis media. Clinical Therapeutics 11, Suppl. A, 35-47.
22. Mohs, E., Rodriguez-Solares, A., Rivas, E. & El Hoshy, Z. (1993). A comparative study of azithromycin and amoxycillin in paediatric patients with acute otitis media. Journal of Antimicrobial Chemotherapy 31, Suppl. E, 73-9.
23. Mûller, O. (1993). Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections. Journal of Antimicrobial Chemotherapy 31, Suppl. E, 137-46.
24. Nelson, J. D. (1988). Chronic suppurative otitis media. Pediatric Infectious Diseases 7, 446-8.
25. Paulsen, O., Hoglund, P., Nilsson, L. G. & Bengtsson, H. I. (1987). The interaction of erylhromycin and theophylline. European Journal of Clinical Pharmacology 32, 493-8.
26. Pechère, J.-C. (19930. The use of macrolides in respiratory tract infections. International Journal of Antimicrobial Agents 3, S53-61.
27. Pilot, M. A. & Qin, X. Y. (1988). Macrolides and gastrointestinal motility. Journal of Antimicrobial Chemotherapy 22, Suppl. B, 201-6.
28. Retsema, J., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright, G. et al. (1987). Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrobial Agents and Chemotherapy 31, 1939-47.
29. Royal Pharmaceutical Society of Great Britain. (1993). Martindale, the Extra Pharmacopeia, 30th edn (Reynolds, E. F., Ed.), pp. 126-7. The Pharmaceutical Press, London.
30. Schaad, U. B. (1993). Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children. Journal of Antimicrobial Chemotherapy 31, Suppl. E, 81-8.
31. Soliman, H. & Said, A. (1992). Oral azithromycin capsules, a new azalide in upper respiratory tract infections. Journal of the Egyptian Medical Association 75, 23-30.
32. Stillerman, M. (1986). Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis. Pediatric Infectious Diseases 5, 649-54.
33. Waldvogel, F. A. (1988). Summary of cefaclor: a decade of experience. Clinical Therapeutics 11, Suppl A, 536-41.
34. Weippl, G. (1993). Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis or tonsillitis caused by group A streptococci. Journal of Antimicrobial Chemotherapy 31, Suppl. E, 95-101.